Absci Corporation
ABSI
$-0.13
Change (1 day)
$6.72
Year High
$1.35
Year Low
Categories
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Absci Corporation (ABSI) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 2.19 M | -56,405,000 | 41.12 M | 217.3 M | 120.58 M |
| 2022 | 1.55 M | -36,972,000 | 46.59 M | 321.01 M | 186.86 M |
| 2021 | 1.43 M | -232,558,000 | 60.09 M | 426.2 M | 273.08 M |
| 2020 | 1.59 M | -55,367,000 | 178 M | 88.57 M | 73.23 M |
| 2019 | 222 K | -7,070,000 | 60.63 M | 19.47 M | 13.65 M |